Patent · US Active

Controlled release oral pharmaceutical dosage forms comprising MGBG

US9668988B2 · kind B2 · utility

3Cited by
17References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 9, 2014
Grant dateJun 6, 2017
Priority date—
Expiry dateSep 9, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C251/78
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are controlled-release oral pharmaceutical dosage forms comprising MGBG, and their application for the improved treatment of diseases with reduced side effects and/or longer time at maximum concentration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.